Ceramide mediates inhibition of the AKT/eNOS signaling pathway by palmitate in human vascular endothelial cells

Medical Science Monitor

Volumn 15, Issue 9, 2009, Pages

  Xie, Xiao Yun ^a   Chen, Zhuo Xiong ^a   Lei, Min Xiang ^a   He, Xingxuan ^b   Schuchman, Edward H ^b   Liu, Feng ^a   Xu, Han Song ^a   Lin, An Hua ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Ceramide; HUVEC; Insulin; Nitric oxide synthase (NOS); Palmitate; Signal transduction pathway

Indexed keywords

CERAMIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FATTY ACID; INSULIN; NITRIC OXIDE; PALMITIC ACID; PROTEIN KINASE B;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; INHIBITION KINETICS; METABOLITE; SIGNAL TRANSDUCTION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANIMALS; CELLS, CULTURED; CERAMIDES; ENDOTHELIAL CELLS; ENZYME ACTIVATION; ENZYME INHIBITORS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, NONESTERIFIED; FUMONISINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; INSULIN RESISTANCE; METABOLIC SYNDROME X; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PALMITATES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 70349932831     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Steinberg HO, Tarshoby M, Monestel R et al: Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest,1997; 100: 1230-1239 (Pubitemid 27386309)
2. Wang XL, Zhang L, Youker K et al: Free Fatty Acids Inhibit Insulin Signaling-Stimulated Endothelial Nitric Oxide Synthase Activation Through Upregulating PTEN or Inhibiting Akt Kinase. Diabetes, 2006; 55: 2301-2310 (Pubitemid 44743628)
3. Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of theevidence. Diabetes Care, 2005; 28: 1769-1778
4. Shulman GI: Cellular mechanisms of insulin resistance. Clin Invest,2000; 106: 171-176
5. Rosolova H, Petrlova B, Simon J et al: High-sensitivity C-reactive protein and the hypertriglyceridemic waist in patients with type 2 diabetes and metabolic syndrome. Med Sci Monit, 2008; 14(8): CR411-15
6. Dresner A, Laurent D, Marcucci M et al: Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest, 1999; 103: 253-259 (Pubitemid 29053143)
7. Kuhlmann J, Neumann-Haefelin C, Belz U et al: Intramyocellular lipid and insulin resistance: a longitudinal in vivo 1H-spectroscopic study in Zuckerdiabetic fatty rats. Diabetes, 2003; 52: 138-144
8. Turinsky J, O'Sullivan DM, Bayly BP: 1,2-Diacylglycerol and ceramide. levels in insulin-resistant tissues of the rat in vivo. J Biol Chem, 1990; 265: 16880-16885
9. Summers SA, Garza LA, Zhou H, Birnbaum MJ: Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Molecular AND Cellular Biolog,1998; 18: 5457-5464 (Pubitemid 28388128)
10. Hajduch E, Balendran A, Batty IH et al: Ceramide impairs the insulindependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells. Diabetologia, 2001; 44: 173-183 (Pubitemid 32156201)
11. Teruel T, Hernandez R, Lorenzo M: Ceramide Mediates Insulin Resistance by Tumor Necrosis Factor-{alpha} in Brown Adipocytes by Maintaining Akt in an Inactive Dephosphorylated State.Diabetes, 2001; 50: 2563-2571
12. Wang CN, O'Brien L, Brindley DN: Effects of cell-permeable ceramides and tumor necrosis factor-alpha on insulin signaling and glucose uptake in 3T3-L1 adipocytes. Diabetes, 1998; 47: 24-31 (Pubitemid 28030803)
13. Shmueli E, Alberti KG, Record CO: Diacylglycerol/protein kinase C signalling: a mechanism for insulin resistance? Journal of International Medicine, 1993; 234: 397-400
14. Chen KS, Heydrick S, Kurowski T, Ruderman NB: Diacylglycerol-protein kinase C signalling in skeletal muscle: a possible link to insulin resistance. Trans Assoc Am Physicians, 1991; 104: 206-212
15. Chavez JA, Knotts TA, Wang L-P et al: A Role for Ceramide, but Not Diacylglycerol, in the Antagonism of Insulin Signal Transduction by Saturated Fatty Acids. Journal of Biological Chemistry, 2003; 278: 10297-10303
16. Vincent MA, Montagnani M, Michael J: Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium. Current Diabetes Reports, 2003; 3: 279-288 (Pubitemid 38906783)
17. Zeng G, Nystrom FH, Ravichandran LV et al: Roles for insulin receptor, PI3-kinase, and Akt in insulinsignaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation, 2000; 101: 1539-1545
18. Dimmeler Z, Dimmeler S, Chavakis E et al: Migration by an Inhibitory Effect on the Akt/Endothelial Nitric Oxide Synthase.Circulation, 2001; 103: 2102-2107
19. Dimmeler S, Fleming I, Fisslthaler B et al: Activation of nitric oxide synthase in endothelial cells by Akt-dependentphosphorylation. Nature, 1999; 399: 601-605 (Pubitemid 29279182)
20. Svedberg J, Bjorntorp P, Smith U, Lonnroth P: Free fatty acid inhibition of insulin binding, aggregation, and action in isolated rat adipocytes. Diabetes, 1990; 39: 570-574 (Pubitemid 20223782)
21. Nims RW, Cook JC, Krishna MC et al: Colorimetric assays for nitric oxide and nitrogen oxide species formed from nitric oxide stock solutions and donor compounds. Methods Enzymol, 1996; 268: 93-105
22. Zhou Q, Zhang L, Fu X-Q, Chen G-Q. Quantitation of yeast ceramides using high-performance liquid chromatography-evaporative light-scattering detection. Journal of Chromatography, 2002; 780: 161-169 (Pubitemid 35279755)
23. Merrill AH Jr: De Novo Sphingolipid Biosynthesis: A Necessary, but Dangerous, Pathway. J Biol Chem, 2002; 277: 25843-25846
24. McVeigh GE, Cohn JN: Endothelial dysfunction and the metabolicsyndrome. Current Diabetes Reports, 2003; 3: 87-92
25. Montagnani M, Chen H, Barr VA, Quon MJ: Insulin-stimulated activation of eNOS is independent of Ca2- but requires phosphorylation by Akt at Ser(1179). Journal of Biological Chemistry, 2001; 276: 30392-30398 (Pubitemid 37385124)
26. Zeng G, Quon MJ: Insulin-stimulated production of nitric oxide is inhibited by wortmannin: direct measurement in vascular endothelial cells. J Clin Invest, 1996; 98: 894-898 (Pubitemid 26293305)
27. Zeng G, Nystrom FH, Ravichandran LV et al: Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide inhuman vascular endothelial cells.Circulation, 2002; 101: 1539-1545
28. Montagnani M, Ravichandran LV, Chen H et al: Insulin receptor substrate- 1 and phosphoinositide-dependent kinase-1 are required for insulin- stimulated production of nitric oxide in endothelial cells. Molecular Endocrinology, 2002; 16: 1931-1942 (Pubitemid 34828099)
29. Dimmeler S, Fleming I, Fisslthaler B et al: Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature, 1999; 399: 601-605 (Pubitemid 29279182)
30. Schmitz-Peiffer C, Craig DL, Biden TJ: Ceramide Generation Is Sufficient to Account for the Inhibition of the Insulin-stimulated PKB Pathway in C2C12 Skeletal Muscle Cells Pretreated with Palmitate. J Biol Chem, 1999; 274: 24202-24210 (Pubitemid 129528468)
31. 2 Induce Caspase-3-independent Degradation of Akt/Protein Kinase B. Mol. Cell. Neurosci, 2000; 15: 156-169
32. Straczkowski M, Kowalska I, Nikolajuk A et al: Relationship Between Insulin Sensitivity and Sphingomyelin Signaling Pathway in Human Skeletal Muscle. Diabetes, 2004; 53: 1215-1221 (Pubitemid 38569006)
33. Hyde R, Hajduch E, Powell DJ et al: Ceramide down-regulates System A amino acid transport and protein synthesis in rat skeletal muscle cell-sThe FASEB Journal, 2005; 19: 461-463